A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort Study
Conclusion: This model can aid the early identification and screening of the potential risk of neutropenia or FN in the first cycle of treatment for patients using etoposide-based chemotherapy.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Drugs & Pharmacology | Heart | Heart Disease | Hodgkin's Disease | Lymphoma | Study